MicroRNA-216a: a potential therapeutic target for drug resistance and recurrent of liver cancer

doi:10.1016/S1499-3872(13)60104-6

Download: PDF (166 KB) HTML (9 KB)
Export: BibTeX | EndNote (RIS)

Key words： microRNA-216a liver cancer

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles in this journal by
	Chen ZL
	Ma TT
	Huang C
	Xu T
	Hu TT
	Li J

Cite this article:

Chen ZL, Ma TT, Huang C, et al. MicroRNA-216a: a potential therapeutic target for drug resistance and recurrent of liver cancer. Hepatobiliary Pancreat Dis Int 2013; 12(6): 661-661. DOI:10.1016/S1499-3872(13)60104-6

URL:

http://dx.doi.org/10.1016/S1499-3872(13)60104-6 OR http://www.hbpdint.com/EN/Y2013/V12/I6/661

[1]	Shmelev A, Sill AM, Kowdley GC, Sanchez JA, Cunningham SC. Detecting accidental punctures and lacerations during cholecystectomy in large datasets: Two methods of analysis[J]. Hepatobiliary Pancreat Dis Int, 2018, 17(5): 430-436.